Genpharmasec Limited (BOM:531592)
India
· Delayed Price · Currency is INR 2.120
+0.010 (0.47%)
At close: Jun 9, 2025
Genpharmasec Revenue
In the fiscal year ending March 31, 2025, Genpharmasec had annual revenue of 337.22M INR with 10.91% growth. Genpharmasec had revenue of 140.10M in the quarter ending March 31, 2025, with 37.37% growth.
Revenue
337.22M
Revenue Growth
+10.91%
P/S Ratio
3.36
Revenue / Employee
33.72M
Employees
10
Market Cap
1.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 337.22M | 33.16M | 10.91% |
| Mar 31, 2024 | 304.06M | 48.90M | 19.16% |
| Mar 31, 2023 | 255.16M | -18.05M | -6.61% |
| Mar 31, 2022 | 273.21M | 60.13M | 28.22% |
| Mar 31, 2021 | 213.08M | 48.06M | 29.13% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |